Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Neoral (cyclosporine) is more commonly used for organ transplant patients as an anti-rejection drug but is sometimes used in psoriasis. Neoral is available in both pill and liquid form. Cyclosporine ...

Psoriasis is a tricky disease to manage ... First in class In May, the U.S. Food and Drug Administration approved Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist and the first ...

A recent study reaffirmed the safety and effectiveness of guselkumab, in managing psoriasis and psoriatic arthritis over an extended period of 208 weeks (approximately 4 years). This ...

Many cases of mild to moderate psoriasis may be treatable with topical medication. The effectiveness of these treatments varies from person to person, depending on the severity of their psoriasis ...

Jan. 20, 2025 — People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut', according to new research.

Although many topicals have other ingredients, these two are approved by the Food and Drug Administration (FDA) for treating psoriasis. Salicylic acid can help remove and soften skin scales.

The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. The skin condition psoriasis, an overproduction of skin ...

Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular ...

has been accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the treatment of moderate to severe plaque psoriasis. The strategic combination of ...